Graham Capital Management, L.P. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 204 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 16.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
Graham Capital Management, L.P. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2022$2,100,000
+90.9%
60,386
+96.9%
0.08%
+123.7%
Q1 2022$1,100,00030,6680.04%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Broadfin Capital, LLC 1,276,979$14,928,0000.83%
Endurant Capital Management LP 123,259$1,441,0000.48%
TFS CAPITAL LLC 383,030$4,478,0000.43%
Gupta Wealth Management LLC 75,000$877,0000.21%
TURNER INVESTMENTS LLC 89,750$1,049,0000.21%
Spark Investment Management LLC 119,200$1,391,0000.18%
Fiera Capital (Europe) Ltd. 8,451$98,0000.13%
SECOR Capital Advisors, LP 32,981$386,0000.12%
ESSEX INVESTMENT MANAGEMENT CO LLC 39,017$456,0000.08%
Ada Investment Management, LP 10,109$116,0000.06%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders